Diverse membrane-active agents modify the hemolytic response to ferriprotoporphyrin IX

Area of Science:

• Hematology
• Biochemistry
• Membrane Biophysics

Background:

• Ferriprotoporphyrin IX (ferriheme, FP) is released from hemoglobin degradation and acts as a hemolytic agent.
• Erythrocyte membrane integrity is crucial for cell survival and function.
• Various endogenous and exogenous compounds can interact with erythrocyte membranes.

Purpose of the Study:

• To investigate the hemolytic effects of ferriheme (FP) on human erythrocytes.
• To determine how membrane-active agents (chloroquine, mefloquine, quinine, Ca2+, La3+, Mn2+) modulate FP-induced hemolysis.
• To elucidate the mechanisms underlying potentiation and inhibition of hemolysis.

Main Methods:

• Human erythrocytes were incubated with ferriheme (FP) alone or in combination with various agents.
• Hemolytic responses were measured spectrophotometrically at pH 7.4 and 37°C.
• Osmotic fragility and [14C]chloroquine binding assays were performed to study membrane changes.

Main Results:

• Ferriheme (FP) caused hemolysis at concentrations ≥10 µM.
• Non-hemolytic concentrations of chloroquine, mefloquine, quinine, Ca2+, La3+, and Mn2+ potentiated FP-induced hemolysis.
• High chloroquine concentrations paradoxically inhibited hemolysis, and Ca2+ inhibited FP-chloroquine-induced osmotic fragility.

Conclusions:

• The outcome of ferriheme (FP) exposure on erythrocytes depends on the presence and concentration of membrane-active agents.
• Membrane structural changes induced by these agents dictate whether hemolysis is potentiated or inhibited.
• These findings highlight the complex interplay between heme compounds and erythrocyte membrane dynamics.